Geode Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
|
|||||
|
2025
Q1 | $19.8M | Buy |
|
|||||
|
2024
Q4 | $29.4M | Sell |
|
|||||
|
2024
Q3 | $59M | Buy |
|
|||||
|
2024
Q2 | $52.2M | Buy |
|
|||||
|
2024
Q1 | $43M | Buy |
|
|||||
|
2023
Q4 | $35.8M | Buy |
|
|||||
|
2023
Q3 | $27.7M | Buy |
|
|||||
|
2023
Q2 | $38.6M | Buy |
|
|||||
|
2023
Q1 | $37.3M | Buy |
|
|||||
|
2022
Q4 | $22.1M | Buy |
|
|||||
|
2022
Q3 | $28.1M | Buy |
|
|||||
|
2022
Q2 | $26.3M | Sell |
|
|||||
|
2022
Q1 | $36.5M | Buy |
|
|||||
|
2021
Q4 | $39.4M | Buy |
|
|||||
|
2021
Q3 | $44.6M | Buy |
|
|||||
|
2021
Q2 | $41.7M | Buy |
|
|||||
|
2021
Q1 | $38.5M | Buy |
|
|||||
|
2020
Q4 | $22.6M | Buy |
|
|||||
|
2020
Q3 | $14.6M | Sell |
|
|||||
|
2020
Q2 | $13M | Buy |
|
|||||
|
2020
Q1 | $15.8M | Buy |
|
|||||
|
2019
Q4 | $28.7M | Buy |
|
|||||
|
2019
Q3 | $28.9M | Buy |
|
|||||
|
2019
Q2 | $27.7M | Buy |
|
|||||
|
2019
Q1 | $30.8M | Buy |
|
|||||
|
2018
Q4 | $25.6M | Buy |
|
|||||
|
2018
Q3 | $35.7M | Buy |
|
|||||
|
2018
Q2 | $27.4M | Buy |
|
|||||
|
2018
Q1 | $20M | Buy |
|
|||||
|
2017
Q4 | $21.2M | Sell |
|
|||||
|
2017
Q3 | $23.9M | Buy |
|
|||||
|
2017
Q2 | $16.9M | Sell |
|
|||||
|
2017
Q1 | $12.7M | Buy |
|
|||||
|
2016
Q4 | $10.7M | Buy |
|
|||||
|
2016
Q3 | $12.8M | Buy |
|
|||||
|
2016
Q2 | $17.2M | Buy |
|
|||||
|
2016
Q1 | $19.7K | Buy |
|
|||||
|
2015
Q4 | $21.1M | Buy |
|
|||||
|
2015
Q3 | $18.1M | Buy |
|
|||||
|
2015
Q2 | $15.5M | Buy |
|
|||||
|
2015
Q1 | $14.2M | Buy |
|
|||||
|
2014
Q4 | $13.4M | Buy |
|
|||||
|
2014
Q3 | $15M | Buy |
|
|||||
|
2014
Q2 | $15M | Buy |
|
|||||
|
2014
Q1 | $12.8M | Sell |
|
|||||
|
2013
Q4 | $7.89M | Sell |
|
|||||
|
2013
Q3 | $11.6M | Buy |
|
|||||
|
2013
Q2 | $12.4M | Buy |
|